These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29358208)

  • 21. Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States.
    Davidson PJ; Lopez AM; Kral AH
    Int J Drug Policy; 2018 Mar; 53():37-44. PubMed ID: 29278831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam.
    Lambers FA; Stolte IG; van den Berg CH; Coutinho RA; Prins M
    Int J Drug Policy; 2011 May; 22(3):210-8. PubMed ID: 21392958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical studies of harm reduction: Overdose response in uncertain political times.
    Watson TM; Kolla G; van der Meulen E; Dodd Z
    Int J Drug Policy; 2020 Feb; 76():102615. PubMed ID: 31837567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Harm reduction interventions in drug users: current situation and recommendations].
    Bosque-Prous M; Brugal MT
    Gac Sanit; 2016 Nov; 30 Suppl 1():99-105. PubMed ID: 27837802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 21st-century Lazarus: the role of safer injection sites in harm reduction and recovery.
    Strathdee SA; Pollini RA
    Addiction; 2007 Jun; 102(6):848-9. PubMed ID: 17523973
    [No Abstract]   [Full Text] [Related]  

  • 27. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
    Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
    Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.
    Harris RE; Richardson J; Frasso R; Anderson ED
    Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harm-reduction activism: a case study of an unsanctioned user-run safe injection site.
    Kerr T; Oleson M; Wood E
    Can HIV AIDS Policy Law Rev; 2004 Aug; 9(2):13-9. PubMed ID: 15540324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supervised Inhalation Sites: Preventing Overdose and Reducing Health Inequities among People Who Use Drugs.
    Lu A; Kim C; Rosen JG; Thompson E; Tardif J; Welwean R; Park JN
    Subst Use Misuse; 2024; 59(4):520-526. PubMed ID: 38044494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
    Gervasoni JP; Balthasar H; Huissoud T; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2012 Jan; 23(1):33-6. PubMed ID: 21705205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mobile safe injecting facilities in Barcelona and Berlin.
    Dietze P; Winter R; Pedrana A; Leicht A; Majó I Roca X; Brugal MT
    Int J Drug Policy; 2012 Jul; 23(4):257-60. PubMed ID: 22464795
    [No Abstract]   [Full Text] [Related]  

  • 33. The furthest left behind: the urgent need to scale up harm reduction in prisons.
    Sander G; Murphy F
    Int J Prison Health; 2017 Sep; 13(3-4):185-191. PubMed ID: 28914120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Speaking and learning across disciplines in the harm reduction debate.
    Pollack HA
    Int J Drug Policy; 2023 Nov; 121():104108. PubMed ID: 37385918
    [No Abstract]   [Full Text] [Related]  

  • 35. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
    Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fix rooms could prevent infection in addicts.
    Fronzo C
    J Wound Care; 2017 Feb; 26(2):49. PubMed ID: 28182519
    [No Abstract]   [Full Text] [Related]  

  • 37. New Strategies Are Needed to Stop Overdose Fatalities: The Case for Supervised Injection Facilities.
    Gaeta JM; Racine M
    Ann Intern Med; 2018 May; 168(9):664-665. PubMed ID: 29404601
    [No Abstract]   [Full Text] [Related]  

  • 38. Harm reduction and "clean" community: can Viet Nam have both?
    Khuat TH; Nguyen VA; Jardine M; Moore T; Bui TH; Crofts N
    Harm Reduct J; 2012 Jul; 9():25. PubMed ID: 22769430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011.
    Marotta PL; McCullagh CA
    Int J Drug Policy; 2016 Jun; 32():3-10. PubMed ID: 27212656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prospect of implementing a Safer Injection Facility in San Francisco: perspectives of community stakeholders.
    Wenger LD; Arreola SG; Kral AH
    Int J Drug Policy; 2011 May; 22(3):239-41. PubMed ID: 21334185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.